How do italian pharmacoeconomists evaluate indirect costs?

Value in Health

Volumn 3, Issue 4, 2000, Pages 270-276

  Garattini, Livio ^a,b   Tediosi, Fabrizio ^a   Ghislandi, Simone ^a   Orzella, Letizia ^a   Rossi, Carlotta ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

Indirect costs; Italy; Methodology; Pharmacoeconomics

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG COST; ECONOMIC ASPECT; HEALTH ECONOMICS; HUMAN; ITALY; PRIORITY JOURNAL; PRODUCTIVITY; STANDARDIZATION;

EID: 0033785792     PISSN: 10983015     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4733.2000.34004.x     Document Type: Article

References (40)

1. Current trends in the use of pharmacoeconomics and outcomes research in Europe
2. Labour and health status in economic evaluation of health care: The Health Labour Questionnaire
3. The impact of indirect costs on outcomes of health care programs
4. How to calculate indirect costs in economic evaluations
5. The friction cost method: A comment
6. The friction cost method for measuring indirect costs of disease
7. Indirect costs in economic studies
8. La determinazione del prezzo dei farmaci innovativi in Italia registrati con procedura centralizzata europea
9. The new pharmaceutical policy in Italy
10. Farmacoeconomia e azienda farmaceutica
11. A proposal for Italian guidelines in pharmacoeconomics
12. Lineeguida per la conduzione di studi sull'efficacia e sul costo dei trattamenti farmacologici
13. Raccomandazioni per la conduzione degli studi di farmacoeconomia: La guida GISF
14. Il costo sociale della malattia di Alzheimer. Metodologia e risultati di un indagine preliminare
15. Direct and indirect costs of major depression: Implementing a study methodology in a public psychiatric service
16. The economic and social burden of Alzheimer Disease on families in the Lombardy region of Italy
17. Cost of an outbreak of Hepatitis A in Puglia, Italy
18. Epidemiology and cost analysis of varicella in Italy: Results of a sentinel study in the paediatric practice
19. Trattamento chirurgico di cisti ovariche: Analisi economica come strumento di programmazione e di valutazione di tecniche
20. I costi sociali dell'asma bronchiale
21. Il costo sociale del morbillo in eta pediatrica. L'epidemia a Palermo nel 1996/1997
22. Hospitalat-home for advanced cancer patients within the framework of the Bologna Eubiosia project: An evaluation
23. Cost-comparison of different management policies for tuberculosis patients in Italy
24. Cost-effectiveness of interferon alfa in chronic myelogenous leukemia
25. Economic analysis of two structured treatment and teaching programs on asthma
26. An economic evaluation of universal pertussis vaccination in Italy
27. Immunization programme against Hepatitis B virus infection: Cost-effectiveness
28. Il costo dell'asma in Italia
29. Cost-of-illness of epilepsy in Italy
30. Direct and indirect costs of schizophrenia in community psychiatric services in Italy
31. Valutazione dei costi di un'epidemia influenzale nella popolazione lavorativa di Siena